glp 1 hearing loss Risk of peripheral vestibular disorders and impairment among users of glucagon-like peptide-1 receptor agonists The promise and peril of

Highlights The first incretin hormone, gastric inhibitory peptide, was identified in the early 1970s, followed by the discovery of glucagonlike peptide 1 (GLP-1) in the 1980s [1]

In the STEP 1 trial, approximately 3840% of total weight lost during semaglutide treatment came from lean mass

It does not provide medical advice or determine eligibility for any treatment

Now, recently there's been some new research coming out that makes a pretty good case for combining hormone replacement therapy or menopause, , hormone therapy with GLP one therapy

Merck, Roche, AstraZeneca, and Lilly all rose in the rankings with Lilly pushing GSK out of the top 10